Carregant...
Lean body weight and metformin are insufficient to prevent endometrial hyperplasia in mice harboring inactivating mutations in PTEN
OBJECTIVES: Obesity is a major risk factor for endometrial cancer. We evaluated whether obesity exacerbates progression of endometrial hyperplasia (EH) using the PRCre/+ PTENflox/+ mouse model and examined if the type-2-diabetes drug, metformin, could prevent EH. METHODS: Twenty obese (PRCre/+ PTEN...
Guardat en:
| Publicat a: | Oncology |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5285472/ https://ncbi.nlm.nih.gov/pubmed/27931017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000450615 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|